urology
Astellas has an extensive background in urology, making the company in this field of medicine a world leader. This is due to an excellent portfolio of medications in this area.

In Astellas, we focus our resources and experience in areas where medical needs are still not met. Astellas leads the development of innovative treatments for Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Through our commitment to ongoing research, we are working to identify and develop innovative solutions to current challenges in urology and offer patients hope for a better future.

EN_PIL Betmiga | EN_PIL Omnic Tocas | EN_PIL_Vesicare tabs | EN_PIL_Vesomni | EN_Vesicare OS

Learn more about our therapeutic areas:

Oncology

Through research programs, we aim to change the tomorrow of patients suffering from solid tumours, such as Prostate Cancer, and haematologic malignancies.

Urology

Focused on research to meet the needs in Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Transplantation

Innovative therapies for the prevention and treatment of organ rejection

Anti-infectives

We tackle the complex challenges of Fungal and Bacterial Infections

NON_2019_0011_GR

Innovation

RELATED LINKS

R & D

Research and Development is at the core of everything we do. It not only drives our work today, but it fosters the work we will do tomorrow...

Read More